Ezekowitz Alan is a director of Fulcrum Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Organon & Co.
11 Jun 24
4
Fulcrum Therapeutics, Inc.
29 Jun 23
4
Organon & Co.
13 Jun 23
4
Fulcrum Therapeutics, Inc.
29 Jun 22
4
Organon & Co.
14 Jun 22
4
Fulcrum Therapeutics, Inc.
11 Jun 21
4
Organon & Co.
8 Jun 21
3
Organon & Co.
2 Jun 21
4
Fulcrum Therapeutics, Inc.
7 Dec 20
4
Fulcrum Therapeutics, Inc.
15 Jun 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
7 Jun 24 | OGN Organon & Co. | Phantom Stock Common Stock | Grant | Acquire A | No | No | 20.75 | 9,638.554 | 200.00 k | 36,454.814 |
27 Jun 23 | FULC Fulcrum Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 3.16 | 30,000 | 94.80 k | 30,000 |
9 Jun 23 | OGN Organon & Co. | Phantom Stock Common Stock | Grant | Acquire A | No | No | 19.83 | 10,086 | 200.01 k | 25,285 |